Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY
Laurus Labs moved higher in a quarterly results development for Q2FY27.
· Economic Times Markets, ET Stocks
Laurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-year to Rs 2,206 crore, while net profit more than doubled to Rs 441 crore. Growth was supported by sustained momentum in its CDMO business and Affordable Medicines division, alongside improving margins and continued investments in manufacturing capabilities.
Key facts
- Period
- Q2FY27
The analysis
Laurus Labs reported Rs 2,329, Rs 2,206 crore and Rs 441 crore for Q2FY27, with movement of 4%, 33% and 126% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is +6.0% on the day at ₹2,377.50, and has returned +26.0% over three months. It is trading close to its 52-week high, so expectations were already elevated going in. The pharma & healthcare sector has moved -2.1% over the same period, so Laurus Labs is running 28.1 points ahead of its peers.
For Laurus Labs, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- In focus: Laurus Labs (LAURUSLABS), in Pharma & Healthcare.
- Over three months: Laurus Labs +26.0% against Pharma & Healthcare -2.1% (28.1 points ahead).
- Trading well above normal today: Laurus Labs at 3.8 times its 20-day average volume.
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Laurus LabsLAURUSLABS · Pharma & Healthcare | ₹2,377.50 | +6.0% | +13.4% | +26.0% | +5.9% | 3.8× | — |
Pharma & Healthcare
1M -3.2% · 3M -2.1%
Laurus Labs
Prices as of 30 Oct 2026, 13:17 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Laurus Labs Q2 Review: Brokerages Split As Jefferies Raises Target, Two Retain Sell
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
India's pharma, healthcare deal volumes rise 23% in Q3 2026: Report
Syngene International shares surge 12%, biggest 1-day gain in 6 years; what drove the rally despite a Q2 profit drop?
Jio Platforms shares to be available under MTF from Day 1. What should investors know?